sever
pneumonia
ard
caus
human
adenoviru
infect
rare
devast
diseas
rapid
progress
multiorgan
failur
death
howev
case
report
far
infect
appear
associ
increas
diseas
sever
higher
mortal
infect
critic
ill
patient
possibl
factor
contribut
infect
underli
psychiatr
diseas
result
institution
respect
patient
polytoxicomania
control
data
therapi
sever
adenoviru
infect
lack
remain
experiment
conclus
data
infect
caus
sever
pneumonia
ard
scarc
control
clinic
trial
therapi
adenoviru
pneumonia
non
exist
thu
establish
therapi
far
icu
physician
awar
potenti
devast
diseas
studi
need
ca
pfortmuel
mariateresabarbani
ifikunibech
mt
barbani
joergschefold
inselch
jc
schefold
heimalbert
mhhannoverd
heim
stefanzimmerli
inselch
zimmerli
acut
respiratori
distress
syndrom
ard
lifethreaten
diseas
character
fluid
accumul
interstiti
alveolar
space
due
increas
vascular
permeabl
result
inflamm
infecti
pneumonia
common
diseas
lead
ard
viral
pneumonia
account
approxim
pneumonia
case
howev
proport
viral
pneumonia
lead
ard
unknown
infect
respiratori
virus
associ
high
incid
lung
injuri
ard
increas
mortal
includ
influenza
avian
influenza
virus
sar
merscoronavirus
human
adenovirus
frequent
caus
acut
upper
respiratori
tract
infect
children
high
respiratori
morbid
particular
immunecompromis
host
interestingli
adenovirus
affect
almost
organ
system
depend
adenoviru
type
host
factor
eg
immunodefici
adenoviru
infect
mostli
selflimit
immunecompet
patient
treatment
mainli
reli
support
measur
life
threaten
adenoviru
infect
eg
viral
pneumonia
ard
report
associ
adenoviru
type
appear
rare
case
mainli
attribut
dissemin
infect
adenoviru
serotyp
belong
subgroup
virus
report
two
case
sever
ard
caus
highli
virul
strain
adenoviru
subtyp
review
literatur
adenovirusinduc
ard
year
old
male
patient
refer
hospit
outpati
psychiatr
clinic
due
upper
respiratori
tract
infect
progress
lower
respiratori
tract
involv
patient
present
worsen
tachypnoea
increas
respiratori
distress
person
histori
includ
paranoid
schizophrenia
histori
intraven
drug
use
current
enrol
offici
drug
substitut
program
structur
epilepsi
chronic
hepat
c
amoxicillin
clavulan
acid
clarithromycin
prescrib
suspect
pneumonia
admit
normal
ward
within
short
time
respiratori
function
deterior
rapidli
transfer
intens
care
unit
icu
intub
antibiot
therapi
escal
piperacillintazobactam
initi
patient
present
clinic
pictur
suggest
septic
shock
hyperdynam
cardiocirculatori
failur
due
mark
vasoplegia
differenti
catecholamin
volum
therapi
start
bilater
pleural
effus
drain
ensu
day
condit
stabil
declin
inflamm
paramet
observ
catecholamin
support
stop
cultur
respiratori
specimen
without
growth
five
day
later
secondari
declin
respiratori
function
observ
imag
studi
suggest
ard
lung
protect
ventil
initi
prone
posit
perform
antibiot
therapi
chang
cefepim
metronidazol
laboratori
paramet
document
increas
system
inflamm
creactiv
protein
crp
mgl
patient
develop
pancytopenia
white
blood
cell
count
hemoglobin
gl
platelet
count
l
pcr
highviru
load
detect
plasma
bronchoalveolar
lavag
bal
fluid
despit
extens
medic
therapi
patient
develop
rapidli
deterior
multiorgan
dysfunct
instal
extra
corpor
membran
ecmo
support
care
consid
decid
patient
die
shortli
put
comfort
care
autopsi
confirm
sever
ard
bilater
diffus
parenchym
defect
interstiti
thicken
addit
hemorrhag
infarct
right
upper
lobe
note
year
old
femal
present
region
hospit
twoweek
histori
lower
respiratori
tract
infect
respond
treatment
amoxicillin
clavulan
acid
day
person
histori
includ
seroposit
rheumatoid
arthriti
treat
infliximab
leflunomid
borderlin
psychiatr
diseas
despit
escal
antibiot
therapi
piperacillintazobactam
noninvas
ventil
respiratori
function
worsen
rapidli
patient
intub
transfer
icu
admiss
patient
sever
ard
oxygen
index
need
mechan
ventil
high
ventilatori
pressur
plateau
pressur
mmhg
diffus
bilater
infiltr
fig
without
evid
cardiac
dysfunct
crp
level
elev
mgl
total
white
blood
cell
count
gl
gl
neutrophil
acut
kidney
injuri
creatinin
umol
sever
nonlact
metabol
acidosi
ph
increas
lactat
dehydrogenas
ul
creatinin
kinas
ul
alaninaminotransferas
ul
evid
reactiv
rheumatoid
arthriti
blood
cultur
taken
icu
admiss
return
neg
antibiot
therapi
chang
meropenem
vancomycin
fluconazol
addit
patient
underw
lung
protect
ventil
prone
posit
well
receiv
inhal
nitricoxid
methylprednisolon
support
care
addit
contin
venoven
hemodiafiltr
progress
acut
kidney
injuri
metabol
acidosi
initi
gastroesophagoscopi
due
suspect
upper
gastrointestin
bleed
show
ubiquit
ulcer
necrot
tissu
lower
esophagu
stomach
acyclovir
ad
treatment
regim
bal
fluid
high
concentr
detect
cidofovir
c
given
addit
despit
maxim
medic
therapi
highdos
catecholamin
support
patient
condit
worsen
progress
venoven
ecmo
support
start
die
day
later
multiorgan
dysfunct
autopsi
perform
adenoviru
detect
quantifi
bal
copiesml
plasma
copiesml
quantit
realtim
pcr
adenoviru
rgene
argen
case
quantit
pcr
perform
case
cycl
threshold
ct
valu
qualit
realtim
pcr
low
bal
plasma
correspond
high
viru
load
specimen
type
viru
load
bal
higher
plasma
similar
case
case
adenoviru
isol
viral
cultur
cell
initi
type
partial
sequenc
hexon
gene
result
complet
genom
sequenc
confirm
result
identifi
viru
subtyp
see
fig
case
adenoviru
dna
also
quantifi
autopt
tissu
specimen
adenoviru
dna
concentr
high
specimen
left
right
lung
copi
adenoviru
dnacel
respect
low
copiescel
organ
tissu
liver
kidney
spleen
stomach
jejunum
colon
pancrea
thyroid
lymph
node
test
except
pancrea
viru
load
copiescel
result
indic
adenoviru
replic
case
almost
complet
limit
lung
tissu
therefor
high
viru
load
detect
plasma
probabl
origin
lung
contrast
dissemin
adenoviru
infect
immunosuppress
patient
result
also
high
viru
load
peripher
blood
caus
viru
replic
multipl
intern
organ
howev
immunosuppress
patient
infect
often
associ
type
adenovirus
healthi
host
may
therefor
replic
rate
differ
organ
infect
case
bacteria
addit
virus
found
bal
fluid
influenza
b
respiratori
syncyti
viru
parainfluenzavirus
human
metapneumoviru
coronavirus
chest
radiograph
case
day
rhinoviru
cytomegaloviru
herp
simplex
viru
type
test
neg
qualit
realtim
pcr
blood
cultur
routin
bacteri
cultur
also
remain
neg
systemat
literatur
search
conduct
medlin
www
pubmedorg
follow
mesh
term
adenoviru
adenoviru
pneumonia
adenoviru
sever
pneumonia
adenoviru
ard
follow
exclus
criteria
appli
articl
featur
infect
articl
languag
english
german
articl
biolog
microbiolog
aspect
adenoviru
infect
relat
clinic
practic
articl
older
year
older
clinic
work
exclud
describ
nonvirul
strain
circul
europ
literatur
research
result
articl
relat
infect
five
public
exclud
report
microbiolog
technic
detail
relat
clinic
practic
avail
russian
see
tabl
remain
paper
use
evalu
includ
paper
summar
tabl
first
paper
present
result
cluster
analysi
emerg
sever
respiratori
tract
infect
caus
adenovirus
oregon
usa
ten
percent
patient
infect
third
common
type
adenoviru
isol
follow
adenoviru
patient
suffer
articl
russian
adenoviru
infect
significantli
older
infect
adenoviru
type
infect
result
pneumonia
case
requir
hospit
thirti
patient
admit
icu
requir
mechan
ventil
fatal
note
second
public
describ
case
seri
case
infect
germani
patient
age
rang
month
year
four
seven
patient
male
six
patient
suffer
sever
pneumonia
one
keratoconjunct
patient
pneumonia
requir
hospit
icu
mechan
ventil
two
receiv
ecmo
therapi
two
other
ecmo
die
interestingli
four
seven
patient
psychiatr
diseas
schizophrenia
polytoxicomania
one
patient
receiv
immunosuppress
follow
solid
organ
stem
cell
transplant
third
articl
evalu
data
genotyp
adenoviru
infect
us
hospit
month
observ
infect
associ
sever
diseas
adenovirida
ubiquit
dna
virus
associ
respiratori
diseas
also
gastrointestin
ophthalmolog
cardiac
neurolog
genitourinari
infect
depend
tropism
adenoviru
type
caus
infect
adenovirida
compris
speci
pathogen
human
ag
differ
adenoviru
type
classifi
transmiss
occur
droplet
via
fecalor
rout
via
contamin
fomit
viral
shed
respiratori
gastrointestin
tract
may
continu
week
even
asymptomat
patient
incub
period
day
immunocompet
patient
diseas
typic
selflimit
persist
infect
note
immuneincompet
host
result
reactiv
sever
diseas
case
secondari
immunosuppress
first
isol
patient
conjunct
although
may
occasion
caus
conjunct
earlier
evid
case
report
children
show
associ
respiratori
tract
infect
caus
sever
broncho
pneumonia
ard
latter
may
associ
emerg
new
subtyp
also
found
two
case
main
genet
featur
subtyp
shorter
penton
rgd
arginineglycineaspart
acid
loop
bind
secondari
cellular
receptor
thu
might
influenc
tropism
virul
moreov
subtyp
found
recombin
genom
gene
region
sequenc
deriv
adenoviru
type
frequent
observ
respiratori
pathogen
even
though
infect
known
sinc
i
affect
major
organ
regular
outbreak
us
militari
sever
infect
report
care
evalu
case
previous
report
one
three
aspect
appear
stand
first
pneumonia
associ
increas
rate
sever
lung
injuri
fatal
outcom
high
virul
current
circul
may
contribut
rapid
diseas
progress
lack
awar
treat
icu
physician
sever
adenovir
lower
respiratori
tract
infect
may
result
delay
treatment
howev
earli
treatment
viral
ard
particularli
relat
diseas
would
make
differ
term
outcom
remain
unclear
effect
antivir
treatment
patient
viral
ard
choic
drug
dosag
treatment
durat
remain
area
debat
research
even
case
preval
influenza
viru
infect
metaanalysi
patient
muthuri
coauthor
found
signific
reduct
mortal
adult
patient
influenza
treat
earli
neuraminidas
inhibitor
effect
mortal
lower
treatment
delay
signific
children
two
recent
publish
studi
support
highdos
treatment
oseltamivir
hand
cochran
review
prevent
treatment
influenza
neuraminidas
inhibitor
found
effect
seriou
influenza
complic
ard
littl
evid
guid
treatment
adenovirusrel
ard
prospect
random
clinic
trial
perform
date
support
use
antivir
agent
adenoviru
infect
cidofovir
brincidofovir
appear
effect
treatment
sever
adenoviru
infect
frequent
use
immunocompromis
patient
none
substanc
approv
indic
therefor
research
certainli
warrant
second
signific
percentag
case
psychiatr
diseas
eg
schizophrenia
drug
abus
suggest
psychiatr
disord
may
make
patient
vulner
adenoviru
infect
close
contact
fellow
inpati
facilit
spread
infect
reduc
standard
hygien
may
import
regard
children
daycar
facil
last
least
patient
psychiatr
disord
may
increas
risk
malnourish
third
respiratori
adenoviru
infect
frequent
transmit
droplet
thu
start
upper
respiratori
tract
infect
adequ
respons
patient
eg
bed
rest
may
limit
delay
spread
infect
lower
respiratori
tract
pneumotrop
adenoviru
type
may
effect
dissemin
respiratori
tract
apic
infect
ciliat
airway
cell
effici
subsequ
viru
shed
airway
tissu
injuri
may
promot
proinflammatori
cytokin
itac
induc
pneumotrop
adenoviru
type
host
factor
impact
occurr
current
unclear
studi
futur
analys
sever
pneumonia
ard
caus
infect
rare
may
fatal
especi
infect
due
appear
associ
increas
diseas
sever
mortal
reason
appar
increas
risk
sever
pulmonari
diseas
patient
underli
psychiatr
diseas
need
elucid
patient
sever
ard
diseas
progress
despit
maxim
therapi
rare
viral
infect
suspect
evalu
real
time
pcr
bal
plasma
fluid
control
data
therapi
sever
adenoviru
infect
lack
use
antivir
drug
like
cidofovir
remain
experiment
conclus
data
infect
caus
sever
pneumonia
ard
scarc
icu
physician
awar
potenti
devast
diseas
studi
need
author
consent
public
applic
